Published in Am J Pathol on September 01, 2000
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J (2004) 1.42
Stem cells and cancer of the stomach and intestine. Mol Oncol (2010) 1.37
Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol (2003) 1.20
Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol (2006) 1.13
Is intestinal metaplasia of the stomach reversible? Gut (2003) 1.01
Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer (2002) 1.00
Chemoprevention of gastric cancer by celecoxib in rats. Gut (2004) 0.98
Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol (2012) 0.97
Mitochondria and energetic depression in cell pathophysiology. Int J Mol Sci (2009) 0.95
Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer (2001) 0.95
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol (2012) 0.94
Nutritional Composition, Antioxidant Activities, and Antiulcer Potential of Lentinus squarrosulus (Mont.) Mycelia Extract. Evid Based Complement Alternat Med (2011) 0.91
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer. World J Gastroenterol (2006) 0.91
Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. Virchows Arch (2004) 0.91
Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol (2004) 0.91
The anti-cancer effect of COX-2 inhibitors on gastric cancer cells. Dig Dis Sci (2007) 0.91
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma. Cancer Prev Res (Phila) (2009) 0.90
Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol (2009) 0.90
Helicobacter pylori promotes apoptosis, activates cyclooxygenase (COX)-2 and inhibits heat shock protein HSP70 in gastric cancer epithelial cells. Inflamm Res (2012) 0.89
Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. Br J Cancer (2013) 0.86
Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland. Virchows Arch (2005) 0.86
Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol (2006) 0.86
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci (2003) 0.85
Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect Immun (2007) 0.85
Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma. World J Gastroenterol (2005) 0.83
Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. World J Gastroenterol (2014) 0.83
Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol (2009) 0.82
Cyclooxygenase-2 expression and its association with thyroid lesions. Arch Med Sci (2010) 0.82
Expressions of MMPs and TIMP-1 in gastric ulcers may differentiate H. pylori-infected from NSAID-related ulcers. ScientificWorldJournal (2012) 0.81
Identification of novel cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo. Mol Cancer (2009) 0.80
Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci (2016) 0.79
Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression. Anat Cell Biol (2013) 0.78
Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol (2004) 0.78
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol (2016) 0.77
Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention. World J Gastroenterol (2005) 0.77
Genomic single nucleotide polymorphisms in the offspring of gastric cancer patients predispose to spasmolytic polypeptide-expressing metaplasia after H. pylori infection. J Biomed Sci (2015) 0.77
Polysaccharide-rich fraction of Termitomyces eurhizus accelerate healing of indomethacin induced gastric ulcer in mice. Glycoconj J (2013) 0.77
Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract. Pharmaceuticals (Basel) (2010) 0.75
Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding. BMC Gastroenterol (2011) 0.75
An immunohistochemical study of canine spontaneous gastric polyps. Diagn Pathol (2014) 0.75
Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases. World J Gastroenterol (2012) 0.75
Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection. Front Med (Lausanne) (2017) 0.75
From inflammation to gastric cancer: Role of Helicobacter pylori. Oncol Lett (2016) 0.75
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk. Clin Infect Dis (2017) 0.75
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res (1995) 4.52
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res (1998) 3.79
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med (1999) 3.57
Altered eicosanoid levels in human colon cancer. J Lab Clin Med (1993) 3.32
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res (1999) 3.00
Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res (1997) 2.99
Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res (1998) 2.92
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol (1996) 2.87
Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol (1995) 2.64
Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res (1999) 2.51
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res (1998) 2.00
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res (1998) 1.94
Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol (1999) 1.83
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med (1998) 1.58
Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol (1998) 1.57
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology (1997) 1.35
Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology (1999) 1.34
Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol (2000) 1.33
Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol (1999) 1.28
Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta (1995) 1.26
The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene (1996) 1.18
Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol (1999) 1.12
Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol (1996) 1.03
Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids (1998) 0.99
Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res (1999) 0.97
Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol (1998) 0.97
Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells. Biochim Biophys Acta (1999) 0.96
The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J Surg Res (1999) 0.88
Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL.19A. Anticancer Res (1998) 0.82
Inhibitory effects of indomethacin on growth and proliferation of gastric carcinoma cells KATO III. J Physiol Pharmacol (1993) 0.78
A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet (1993) 8.54
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (2000) 6.98
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med (1995) 5.15
Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol (2005) 5.13
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet (1997) 3.67
CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol (1999) 3.49
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med (2000) 3.12
Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med (1999) 3.07
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med (2001) 3.02
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology (2000) 2.99
Peptic-ulcer disease. Lancet (2002) 2.92
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol (2000) 2.57
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet (2002) 2.52
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc (2007) 2.50
Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ (1997) 2.42
Through-the-scope balloon dilation for pyloric stenosis: long-term results. Gastrointest Endosc (1996) 2.36
Obturator hernia revisited: a review of 12 cases in 7 years. J R Coll Surg Edinb (1997) 2.35
A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity (1995) 2.31
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ (2003) 2.20
Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J (1997) 2.09
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res (2001) 2.07
Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci STKE (2000) 1.96
Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71
Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun (1993) 1.66
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med (2001) 1.62
Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen. Infect Immun (1992) 1.61
EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc (2000) 1.57
Comparison of two-dimensional vs three-dimensional camera systems in laparoscopic surgery. Surg Endosc (1997) 1.50
A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene (1999) 1.49
False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol (1998) 1.48
Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol (1993) 1.46
Oral health status and treatment need of 11-13-year-old urban children in Tibet, China. Community Dent Health (2000) 1.44
Cytopathic effects of the major surface protein and the chymotrypsinlike protease of Treponema denticola. Infect Immun (1998) 1.43
Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol (2008) 1.40
Ultrastructural calcification of glomerular immune complexes. Mod Pathol (1996) 1.39
Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer (2001) 1.38
Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg (2000) 1.37
Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells. Infect Immun (1995) 1.37
The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes. Infect Immun (1996) 1.36
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer (2007) 1.33
Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2001) 1.31
Independent regulation of the extracellular cyclic AMP phosphodiesterase-inhibitor system and membrane differentiation by exogenous cyclic AMP in Dictyostelium discoideum. Dev Biol (1978) 1.30
Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.30
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Ther (2002) 1.23
Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection. Gastrointest Endosc (1995) 1.18
Conservation of msp, the gene encoding the major outer membrane protein of oral Treponema spp. J Bacteriol (1997) 1.18
High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res (2000) 1.17
Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc (1997) 1.15
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer (2004) 1.15
Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol (2001) 1.14
Kaposiform hemangioendothelioma: five patients with cutaneous lesion and long follow-up. Mod Pathol (2001) 1.14
Gastric choriocarcinoma shows characteristics of adenocarcinoma and gestational choriocarcinoma: a comparative genomic hybridization and fluorescence in situ hybridization study. Diagn Mol Pathol (2001) 1.14
High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res (2000) 1.14
Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol (1998) 1.11
Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res (2001) 1.10
Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol (1999) 1.09
Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut (2002) 1.09
Exploring the oral bacterial flora: current status and future directions. Oral Dis (2009) 1.09
Laparoscopic truncal vagotomy and gastroenterostomy for pyloric stenosis. Am J Surg (1996) 1.08
Excimer laser photorefractive keratectomy for myopia: six-month follow-up. J Cataract Refract Surg (1995) 1.06
Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1. Gene (1999) 1.05
A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection. Immunity (1994) 1.05
Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc (2001) 1.05
Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer (1999) 1.03
A randomized comparison of acute phase response and endotoxemia in patients with perforated peptic ulcers receiving laparoscopic or open patch repair. Am J Surg (1998) 1.02
Preliminary results from a field study of wild Guizhou snub-nosed monkeys (Rhinopithecus brelichi). Folia Primatol (Basel) (1993) 1.01
Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer (2002) 1.00
Comparison of two rapid whole-blood tests for Helicobacter pylori infection in Chinese patients. J Clin Microbiol (1998) 1.00
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy. Cancer Chemother Pharmacol (2007) 1.00
Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET). J Cell Biochem (2001) 0.99
Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther (2002) 0.99
Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer. Br J Cancer (2009) 0.99
Gastroesophageal reflux, motility disorders, and psychological profiles in the etiology of globus pharyngis. Laryngoscope (1997) 0.99
Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol (2001) 0.99
Chemoprevention of gastric cancer by celecoxib in rats. Gut (2004) 0.98
Follicular dendritic cell sarcoma of the neck: report of two cases complicated by pulmonary metastases. Cancer (2000) 0.98